Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

13.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-definition GWAS of IBS in 2.8 million individuals reveals cardiometabolic and triglyceride-linked mechanisms.

Gut·2026
Same author

Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer.

Cancer research·2026
Same author

Human haematopoietic stem cells remember inflammatory stress.

Nature·2026
Same author

<i>Trans</i>-eQTLs reveal the architecture of human gene regulatory networks.

medRxiv : the preprint server for health sciences·2026
Same author

Provincial variation and associated factors in adherence to cervical cancer screening in Canada: Evidence from the Canadian Partnership for Tomorrow's Health.

Journal of medical screening·2026
Same author

Psychosocial factors and the risk of cancer: An individual-participant data meta-analysis.

Cancer·2026

Related Experiment Video

Updated: Sep 25, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Inferring ongoing cancer evolution from single tumour biopsies using synthetic supervised learning.

Tom W Ouellette1,2, Philip Awadalla1,2

  • 1Ontario Institute for Cancer Research, Department of Computational Biology, Toronto, Ontario, Canada.

Plos Computational Biology
|April 28, 2022
PubMed
Summary

TumE, a new supervised learning method, accurately infers cancer evolution from variant allele frequencies (VAF) in tumors. This approach speeds up analysis and enhances understanding of subclonal selection in cancer genomics.

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

Related Experiment Videos

Last Updated: Sep 25, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

Area of Science:

  • Computational biology
  • Cancer genomics
  • Machine learning

Background:

  • Variant allele frequencies (VAF) reflect tumor evolution and subclonal selection.
  • Existing VAF analysis methods are often slow, computationally intensive, or inaccurate.

Purpose of the Study:

  • To develop a novel supervised learning method, TumE, for inferring cancer evolution from bulk-sequenced tumor biopsies.
  • To improve the accuracy and efficiency of detecting positive selection, deconvoluting subclonal populations, and estimating subclone frequencies.

Main Methods:

  • TumE integrates simulated cancer evolution models with Bayesian neural networks.
  • The method utilizes a synthetic supervised learning approach for training.

Main Results:

  • TumE demonstrates significant improvements in accuracy and inference time for detecting positive selection and estimating subclone frequencies.
  • Analyses in both synthetic and patient tumors validate the method's performance.
  • Transfer learning capabilities within TumE reduce data and computational requirements for related tasks.

Conclusions:

  • TumE offers a powerful and efficient framework for cancer evolutionary inference using VAF data.
  • The developed library of recyclable deep learning models supports the cancer evolution research community.
  • This work lays the foundation for advanced computational methods in cancer genomics to benefit patients.